관련문헌 등
·대한신경외과학회, 신경외과학: 학생과 전공의를 위한 교과서, 대한신경외과학회, 2012
·Rakel D, Integrative Medicine, 2018
·Moreno M 등, Cognitive Improvement in Mild to Moderate Alzheimer’s Dementia After Treatment with the Acetylcholine Precursor Choline Alfoscerate:
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial, Clinical Therapeutics, Vol. 25, No. 1, 2003
·Amenta F 등, The ASCOMALVA trial: Association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: Interim results, Journal of the Neurological Sciences 322 (2012) 96？101
·Amenta F 등, The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer’s Disease) Trial: Interim Results after Two Years of Treatment, Journal of Alzheimer’s Disease 42 (2014) S281？S288
·Rea R 등, Apathy Treatment in Alzheimer’s Disease: Interim Results of the ASCOMALVA Trial, Journal of Alzheimer’s Disease 48 (2015) 377？383
·Carotenuto A 등, The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer’s Disease: Interim Results of the ASCOMALVA Trial, Journal of Alzheimer’s Disease 56 (2017) 805？815
·Perri R 등, A Multicentre Trial to Evaluate the Efficacy and Tolerability of α-Glycerylphosphorylcholine versus Cytosine Diphosphocholine in Patients with Vascular dementia, The Journal of International Medical Research 1991: 19: 330-341
·Parnetti L등, Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type, Drugs Aging 3(2):159-164. 1993